Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Procyon files IND for PCK-3145

Dec. 17, 2004

Vion updates phase II Triapine-gemcitabine study in pancreatic cancer

Dec. 17, 2004

New conjugate carrier for effective antitumor boron neutron capture therapy

Dec. 17, 2004

Bionomics receives START grant extension for breast cancer efforts

Dec. 17, 2004

Jak-Stat inhibitor shows promise for the treatment of AML

Dec. 17, 2004

Anticancer activity of KOS-953 further characterized in vitro and in vivo

Dec. 16, 2004

Phase I evaluation of CG-53135 successful in cancer patients

Dec. 16, 2004

AMN-107 active in imatinib-resistant chronic myelogenous leukemia

Dec. 16, 2004

Novel nucleoside analogue shows potent activity in breast cancer model

Dec. 16, 2004

Kinase inhibitors in early development at ImClone

Dec. 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...